Workflow
Zhi Tong Cai Jing
icon
Search documents
广济药业拟定增募资不超6亿元
Zhi Tong Cai Jing· 2026-02-11 15:01
广济药业(000952)(000952.SZ)发布2026年向特定对象发行A股股票预案,本次向特定对象发行股票的 发行对象为公司控股股东长江产业集团,发行对象符合法律、法规的规定。本次发行的股票全部采用现 金方式认购。预计募集资金总额不超过6亿元(含本数),扣除发行费用后用于偿还借款和补充流动资 金。 ...
豪威集团因部分行使超额配股权而发行494.11万股
Zhi Tong Cai Jing· 2026-02-11 14:58
Core Viewpoint - The announcement from Glory Group (603501) indicates the issuance of approximately 11,400 shares due to the exercise of options and an additional issuance of 4.9411 million H-shares due to partial exercise of the over-allotment option [1] Group 1 - Glory Group will issue approximately 11,400 shares on February 11, 2026, as a result of options being exercised [1] - The company will also issue and allocate 4.9411 million H-shares due to the partial exercise of the over-allotment option [1]
赣锋锂业:提名徐建章为独立非执行董事候选人
Zhi Tong Cai Jing· 2026-02-11 14:58
Core Viewpoint - Ganfeng Lithium (002460)(01772) announced the resignation of Ms. Xu Yixin as an independent non-executive director and proposed Mr. Xu Jianzhang as her replacement, pending shareholder approval [1] Group 1 - Ms. Xu Yixin will step down from her position as an independent non-executive director [1] - The board has agreed to nominate Mr. Xu Jianzhang as the candidate for independent non-executive director [1] - Mr. Xu Jianzhang's term will align with the sixth board's term, starting from the date of his election by shareholders and the expiration of Ms. Xu's term, excluding consecutive re-elections [1]
华昱高速拟折让约19.27%配股 最多净筹约5055.638万港元
Zhi Tong Cai Jing· 2026-02-11 14:58
Core Viewpoint - Huayu Expressway (01823) plans to place a maximum of 58.5 million shares at HKD 0.88 each, representing a discount of approximately 19.27% from the last closing price of HKD 1.09 on the Hong Kong Stock Exchange [1] Summary by Category - **Share Placement Details** - The company intends to place shares through a placement agent to no fewer than six subscribers [1] - The maximum net proceeds from the placement are approximately HKD 50.56 million [1] - **Use of Proceeds** - Approximately 80% of the proceeds will be allocated for employee salaries, rent, professional fees, and other administrative expenses [1] - About 20% will be used for sales, promotion, and marketing expenses [1]
GUANZE MEDICAL获富德(香港)投资控股折让约84.0%提现金要约 2月12日复牌
Zhi Tong Cai Jing· 2026-02-11 14:58
GUANZE MEDICAL(02427)及要约人富德(香港)投资控股有限公司联合公布,董事会获售股股东告知, 于2026年1月28日,要约人(作为买方)与售股股东Meng A Capital Limited(作为卖方)订立买卖协议,以向 售股股东收购6.99亿股股份,占本公司于本联合公告日期已发行股本总数约73.60%,总代价为1.75亿港 元(相当于代价每股股份0.25港元)。 此外,本公司已向联交所申请股份自2026年2月12日(星期四)上午九时正起恢复买卖。 要约价每股要约股份0.25港元,较在最后交易日(即2026年1月26日)于联交所所报收市价每股股份1.560 港元折让约84.0%。 要约人为一间于2015年9月17日在香港注册成立的有限责任公司,主要从事股票及股权投资。于本联合 公告日期,要约人由张峻先生(张先生)及陶美萦女士(陶女士)分别最终实益拥有94%及6%。于本联合公 告日期,要约人由富德控股(集团)有限公司(一间于中国成立的公司)直接全资拥有,而富德控股(集团)有 限公司则由深圳市峻德投资有限公司(一间于中国成立的公司)(由张先生全资拥有)、张先生、深圳市富 源祥投资有限公司(一间于 ...
芯化兰德拟发行合共5517万股H股
Zhi Tong Cai Jing· 2026-02-11 14:52
芯化兰德(08106)发布公告,于2026年2月11日,本公司已与六名认购人订立六份独立认购协议,本公司 已有条件同意以每股H股0.31港元的认购价配发及发行合共5517万股H股。H股认购股份将根据一般授权 配发及发行。 六名认购人将合共认购5517万股H股,其总面值为人民币551.7万元,且分别约占于本公告日期本公司已 发行H股股本总数及经各认购事项完成后扩大的本公司已发行H股股本的21.05%及17.39%;及于本公告日 期本公司已发行股本总数及经各认购事项完成后扩大的本公司已发行股本的10.89%及9.82%。 认购事项所得款项净额(经扣除所有适用成本及开支后)将约为1671万港元, ...
连连数字2月11日斥资120.96万港元回购18.1万股
Zhi Tong Cai Jing· 2026-02-11 14:52
连连数字(02598)发布公告,于2026年2月11日,该公司斥资120.96万港元回购18.1万股。 ...
有道(DAO.US)涨逾2% 2025年首次实现全年经营性现金净流入
Zhi Tong Cai Jing· 2026-02-11 14:51
Core Viewpoint - NetEase Youdao (DAO.US) reported a solid financial performance for the fiscal year 2025, achieving significant growth in revenue and operating profit, indicating improved financial health and operational efficiency [1] Financial Performance Summary - For the fiscal year 2025, Youdao's total net revenue reached 5.91 billion yuan, representing a year-on-year increase of 5.0% [1] - The operating profit for the year was 220 million yuan, showing a substantial year-on-year growth of 48.7% [1] - The company achieved its first annual operating cash inflow of 55.2 million yuan, highlighting enhanced financial health and self-sustainability [1] Quarterly Performance Summary - In Q4 2025, Youdao continued its profitable trend with net revenue of 1.56 billion yuan, marking a year-on-year increase of 16.8% [1] - The operating profit for the fourth quarter was 60.2 million yuan, driven by strategic investments in high-growth areas such as Youdao Lingxi and advertising services [1] - The operating cash inflow for the quarter reached 180 million yuan, reflecting a year-on-year growth of 16.4% [1] Management Commentary - The CEO of NetEase Youdao, Zhou Feng, emphasized the company's achievement of annual operating cash inflow for the first time and noted steady growth in learning services, online marketing services, and AI subscription services, showcasing the increasing resilience of the company's business [1]
皓文控股及澄迈钧立将开展战略性合作,以发展及拓展澄迈钧立的业务
Zhi Tong Cai Jing· 2026-02-11 14:46
董事努力探索新的机遇,以提升本集团的业绩。该合作将使本集团多元化业务,并拓宽收入来源。董事 对澄迈钧立业务的长远前景持乐观态度,并认为潜在合作符合本集团及本公司股东的整体利益。 根据谅解备忘录,本公司及澄迈钧立将开展战略性合作,以发展及拓展澄迈钧立的业务(尤以天然橡胶 及相关农业领域为重)。本公司与澄迈钧立将探索在农业及相关产业应用生物科技、智能技术及绿色科 技,致力于构建数字化平台,推动专利成果的复製与商业化,并透过香港实现海外扩张。 皓文控股(08019)发布公告,于2026年2月11日,本公司与澄迈钧立橡胶有限公司(澄迈钧立)订立一项不 具法律约束力的谅解备忘录(谅解备忘录)。 ...
家乡互动2月11日斥资2.77万港元回购2万股
Zhi Tong Cai Jing· 2026-02-11 14:46
家乡互动(03798)发布公告,于2026年2月11日斥资2.77万港元回购2万股。 ...